Dibutyryl cAMP improves systemic vasoconstriction caused by endotoxin in dogs

Shock

Volumn 5, Issue 4, 1996, Pages 284-288

  Yanase, Takashi ^a   Enzan, Keiji ^b   Mitsuhata, Hiromasa ^c   Horiguchi, Takashi ^b  

^a Tokyo Metropolitan Health and Medical Treatment Corporation   (Japan)

^b AKITA UNIVERSITY   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUCLADESINE; CYCLIC AMP; LIPOPOLYSACCHARIDE; THROMBOXANE B2;

ANIMAL; ARTICLE; BLOOD; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; DOG; DOSE RESPONSE; DRUG EFFECT; ENTEROBACTER INFECTION; HEART OUTPUT; HEMODYNAMICS; LD 50; SEPTIC SHOCK; TIME; VASCULAR RESISTANCE; VASOCONSTRICTION;

ANIMALS; BLOOD PRESSURE; BUCLADESINE; CARDIAC OUTPUT; CYCLIC AMP; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI INFECTIONS; HEMODYNAMIC PROCESSES; LETHAL DOSE 50; LIPOPOLYSACCHARIDES; SHOCK, SEPTIC; THROMBOXANE B2; TIME FACTORS; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 0030122537     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199604000-00009     Document Type: Article

References (30)

1. Kreger BE, Craven DE, McCabe WR: Gram-negative bacteremia. IV. Reevaluation of clinical features and treatment in 612 patients. Am J Med 68:344-355, 1980.
2. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Mtez CA, Balk RA, The Methylprednizolone Severe Sepsis Study Group: A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317:653-658, 1987.
3. The Veterans Administration Systemic Sepsis Cooperative Study Group: Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 317:659-665, 1987.
4. Parker MM, Shelhamer JH, Natanson C, Alling DW, Parrillo JE: Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med 15:923-929, 1987.
5. Morrison DC, Ryan JL: Endotoxins and disease mechanisms. Annu Rev Med 38:417-432, 1987.
6. Grosh S, Liu MS: Decrease in adenylate cyclase activity in dog livers during endotoxin shock. Am J Physiol 245:R737-R742, 1983.
7. Shepherd RE, Lang CH, McDonough KH: Myocardial adrenergic responsiveness after lethal and nonlethal doses of endotoxin. Am J Physiol 252:H410-H416, 1987.
8. Bristow MR, Ginsburg R, Minobe W, et al: Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N Engl J Med 307:205-211, 1982.
9. Adams HR, Baxter CR, Parker JL, Watts NB: Contractile function and rhythmicity of cardiac preparations from E. coli endotoxin-shocked guinea pigs. Circ Shock 13:241-254, 1984.
10. Archer LT, Benjamin BA, Beller-Todd BK, Brackett DJ, Wilson MF, Hinshaw LB: Does LD100 E. coli shock cause myocardial failure? Circ Shock 9:7-16, 1982.
11. Hess ML, Hastillo A, Greenfield LJ: Spectrum of cardiovascular function during Gram-negative sepsis. Prog Cardiovasc Dis 23:279-298, 1981.
12. McDonough KH, Brumfield BA, Lang CH: In vitro myocardial performance after lethal and nonlethal doses of endotoxin. Am J Physiol 250: H240-H246, 1986.
13. Romanosky AJ, Giaimo ME, Shepherd RE, Burns AH: In vitro myocardial performance following in vivo administration of E. coli endotoxin. Circ Shock 19:1-12, 1986.
14. Shepherd RE, McDonough KH, Burns AH: Mechanism of cardiac dysfunction in hearts from endotoxin-treated rats. Circ Shock 19:371-384, 1986.
15. Hanly PJ, Sienko A, Light RB: Role of prostacyclin and thromboxane in the circulatory changes of acute bacteremic Pseudomonas pneumonia in dogs. Am Rev Respir Dis 137:700-706, 1988.
16. Moore JM, Earnest AG, DiSimone AG, Abumrad NN, Fletcher JR: A PAF receptor antagonist, BN52021, attenuates thromboxane release and improves survival in lethal canine endotoxemia. Circ Shock 35:53-59, 1991.
17. Hales CA, Sonne L, Peterson M, Kong D, Miller M, Watkins WD: Role of thromboxane and prostacyclin in pulmonary vasomotor changes after endotoxin in dogs. J Clin Invest 68:497-505, 1980.
18. Postenak T, Sutherland EW, Henion WF: Derivative of cyclic 3′, 5′-adenosine monophosphate. Biochim Biophys Acta 65:558-560, 1962.
19. Skelton CL, Levey GS, Epstein SE: Positive inotropic effects of dibutyryl cyclic adenosine 3′, 5′-monophosphate. Circ Res 26:35-43, 1970.
20. Kukovetz WR, Pöch G: Cardiostimulatory effects of cyclic 3′, 5′-adenosine monophosphate and its acylated derivatives. Naunyn-Schmiedebergs Arch Pharmak 266:236-254, 1970.
21. Webb RC, Bore DF: Relaxation of vascular smooth muscle by isoproterenol, dibutyryl-cyclic AMP and theophylline. J Pharmacol Exp Ther 217:26-35, 1981.
22. Matsui S, Murakami E, Takekoshi N, Emoto J, Matoba M: Hemodynamic effects of dibutyryl cyclic AMP in congestive heart failure. Am J Cardiol 51:1364-1368, 1983.
23. Miyagi Y, Sasayama S, Nakajima H, Fujita M, Asanoi H: Comparative hemodynamic effects of intravenous dobutamine and dibutyryl cyclic AMP, a new inotropic agent, in severe congestive heart failure. J Cardiovasc Pharmacol 15:138-143, 1990.
24. Slotman GJ, Quinn JV, Burchard KW, Burchard KW, Gann DS: Thromboxane, prostacyclin, and the hemodynamic effects of graded bacteremic shock. Circ Res 16:395-404, 1985.
25. Honma M, Satoh T, Takezawa J, Ui M: An ultrasensitive for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue. Biochem Med 18:257-273, 1977.
26. 2α synthesis in mouse hepatocytes. Prostaglandins 36:761-772, 1988.
27. Zheng H, Crowley JJ, Chan JC, Raffin TA: Attenuation of LPS-induced neutrophil thromboxane B2 release and chemiluminescence. J Cell Physiol 146:264-269, 1991.
28. Baker AJ, Fuller RW: Effect of cyclic adenosine monophosphate, 5′-(N-ethylcarboxyamido)-adenosine and methylxanthines on the release of thromboxane and lysosomal enzymes from human alveolar macrophages and peripheral blood monocytes in vitro. Eur J Pharmacol 211:157-161, 1992.
29. Jacobs ER, Soulsby ME, Bone RC, Wilson FJ, Hiller FC: Ibuprofen in canine endotoxin shock. J Clin Invest 70:536-541, 1982.
30. Krausz MM, Utsunomiya T, Feuerstein G, Wolfe JHN, Shepro D, Hechtman HB: Prostacyclin reversal of lethal endotoxemia in dogs. J Clin Invest 67:1118-1125, 1981.